secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eledon Pharmaceuticals, Inc. (ELDN)
CIK:        0001404281
Form:       8-K
Filed at:   2023-06-22T23:59:59+00:00
Accession:  0000950170-23-029259
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eledon shareholders approve 9.6M share increase to 2020 incentive plan at annual meeting
--------------------------------------------------------------------------------

- Amended 2020 Long Term Incentive Plan: share reserve raised from 4.86M to 14.46M shares.
- Two Class III directors re-elected: David-Alexandre C. Gros and Jan Hillson (each ~7.1M for votes).
- Advisory say-on-pay passed with 7.05M for vs 234K against; auditor KMJ Corbin ratified with 9.62M for.
- Plan extended through April 26, 2033; additional 9.6M shares approved by stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404281/000095017023029259/0000950170-23-029259-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404281/000095017023029259/eldn-20230621.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-029259

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer